Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers.
Target Price
The average target price of EYE.AX is 0.37 and suggests 90% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell